One of the key considerations when determining how to implement a wearable or mobile sensor in a clinical trial is how long should a patient wear the device to ensure accurate and reliable measures are obtained. But what constitutes a minimum valid data set? How does participant behavior and technology lapses risk the integrity of the captured data? What are the risks associated with missing data? How can sponsors help reduce burdens for patients?

Signant Health was pleased to be part of the DIA Study Endpoint Communities working group that explored these topics. Find out the answers and more in this illuminating read.

Contributing authors include Marie McCarthy, ICON; Denise Bury, Sanofi-Aventis; Bill Byrom, Signant Health; Cindy Geoghegan, Patient and Partners LLC; and Susan Wong, Transparency Life Sciences.